These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11501680)

  • 1. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

  • 2. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol decanoate: injection site reactions.
    Maharaj K; Guttmacher LB; Moeller R
    J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN; Wazome EG
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length.
    Brahm NC; Washington NB
    J Pharm Pract; 2011 Dec; 24(6):561-3. PubMed ID: 22048930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much haldol D does Larry really need?
    Freudenreich O; McEvoy JP
    J Clin Psychiatry; 1995 Jul; 56(7):331-2. PubMed ID: 7615490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Accidental intravenous administration of haloperidol decanoate].
    Heinz P
    Psychiatr Prax; 1996 Jan; 23(1):42. PubMed ID: 8851235
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate.
    Kane JM
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):20S-23S. PubMed ID: 2870088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.
    Hamann GL; Egan TM; Wells BG; Grimmig JE
    J Clin Psychiatry; 1990 Dec; 51(12):502-4. PubMed ID: 1979555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 14. Alopecia areata associated with haloperidol decanoate long-acting injection.
    Bhattacharya A; Roy D; Hazarika S; Das S; Nath K; Saddichha S
    Aust N Z J Psychiatry; 2012 Jan; 46(1):69. PubMed ID: 22247099
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV; Kravchenko NE; Kopeĭko GI; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):99-104. PubMed ID: 1979463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol decanoate: a depot antipsychotic.
    Hemstrom CA; Evans RL; Lobeck FG
    Drug Intell Clin Pharm; 1988 Apr; 22(4):290-5. PubMed ID: 2897276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
    Pérez C; Stier Rosner SE
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
    Youssef HA
    Clin Neuropharmacol; 1991; 14 Suppl 2():S16-21; discussion S22-3. PubMed ID: 1684308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.